Use of Domestic Polyfunctional Infusion Solution Suksinasol in Clinical Practice

Authors

  • Kh.A. Rasulova Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan
  • B.T. Daminov Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan
  • Y.N. Madjidova Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan
  • F.Kh. Inoyatova Tashkent Medical Academy, Tashkent, Uzbekistan
  • Sh.N. Dadadjanov Tashkent Medical Academy, Tashkent, Uzbekistan
  • I.G. Kim Tashkent Clinical City Hospital №7, Tashkent, Uzbekistan

DOI:

https://doi.org/10.61788/njn.v2i15.04

Keywords:

suksinasol, succinic acid, hypoxia, metabolic disorders, clinical practice

Abstract

This article provides information about a new domestic polyfunctional infusion solution suksinasol, which had success in preclinical and clinical trials. The most important component of the drug is a succinic acid, which is a natural metabolite of the Krebs cycle that can be oxidized in tissues in decrease of oxygen partial pressure. The drug has a regulating effect on the water-salt metabolism, activates the energy metabolism, and normalizes the acid-base status and metabolic processes in cells. It improves microcirculation, restores the hemodynamics and cardiac muscle function in different types of blood loss, shocks, physical activity, and has a diuretic effect. Currently, suksinasol is widely used in different hospitals of Uzbekistan. Safety, economical accessibility, wide opportunities in liquidation of hypoxia, intoxication, dehydration, restoration of circulating blood volume, metabolic and other disorders of homeostasis emphasize certain advantages of suksinasol in comparison with other infusion solutions.

Downloads

Published

10.11.2015

How to Cite

Rasulova, K., Daminov, B., Madjidova, Y., Inoyatova, F., Dadadjanov, S., & Kim, I. (2015). Use of Domestic Polyfunctional Infusion Solution Suksinasol in Clinical Practice. National Journal of Neurology, 2(8), 37–41. https://doi.org/10.61788/njn.v2i15.04